- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 8 residues within 4Å:- Chain C: E.207, P.208, V.250, L.257, N.258, G.373, V.439, S.440
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:V.439
- Hydrogen bonds: C:V.439
NAG-NAG-BMA.4: 7 residues within 4Å:- Chain D: E.207, L.257, N.258, G.373, V.439, S.440
- Ligands: NAG.30
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:G.373
NAG-NAG-BMA.6: 10 residues within 4Å:- Chain G: E.207, V.250, L.257, N.258, N.371, G.373, C.438, V.439, S.440
- Ligands: NAG.46
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:G.373, G:V.439
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 43 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 3 residues within 4Å:- Chain C: N.135, Q.186
- Ligands: NAG.10
Ligand excluded by PLIPNAG.9: 5 residues within 4Å:- Chain C: A.139, T.140, N.152, L.171, Q.316
Ligand excluded by PLIPNAG.10: 5 residues within 4Å:- Chain C: T.133, N.135, S.154, N.156
- Ligands: NAG.8
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain C: V.178, R.188, N.193
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain C: N.226, T.228
- Ligands: NAG-NAG-NAG.1
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain C: E.265, N.285, E.286
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain C: N.297, N.435
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain C: Y.325, N.327, S.406, T.408
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain C: T.366, T.367, N.380, S.382
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain C: N.435, I.436, T.437
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain C: L.261, S.287, N.441
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain C: E.92, N.93
- Chain E: G.16, S.17
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain D: N.135, Q.186
- Ligands: NAG.22
Ligand excluded by PLIPNAG.21: 6 residues within 4Å:- Chain D: A.139, T.140, N.152, L.171, G.315, Q.316
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain D: T.133, N.156, Q.186
- Ligands: NAG.20
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain D: V.178, R.188, N.193
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain D: N.226, T.228, N.236
- Ligands: NAG-NAG-NAG.3
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain D: E.265, N.285, E.286, K.342
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain D: N.297, I.318, G.434
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain D: Y.325, N.327, S.406, T.408
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain D: T.366, T.367, N.380, S.382, R.412
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain D: N.435, I.436, T.437
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain D: L.261, S.287, N.441
- Ligands: NAG-NAG-BMA.4
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain E: P.98, W.99, N.100, T.102, W.103
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain E: S.101, N.105
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain E: Q.141, N.145, N.149
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain F: K.122, E.123, S.125, N.126
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain F: N.100, T.102
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain G: N.135, Q.186
- Ligands: NAG.38
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain G: N.152, N.169, A.170, L.171
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain G: N.135, S.154, F.155, N.156
- Ligands: NAG.36
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain G: R.188, N.193
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain G: N.226, T.228, N.236
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain G: E.265, N.285, E.286, K.342
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain G: N.297
- Ligands: NAG.45
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain G: Y.325, N.327, S.406, I.407, T.408
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain G: T.366, T.367, N.380, S.382
Ligand excluded by PLIPNAG.45: 5 residues within 4Å:- Chain G: T.293, P.295, N.435, T.437
- Ligands: NAG.42
Ligand excluded by PLIPNAG.46: 6 residues within 4Å:- Chain G: N.258, S.287, V.439, S.440, N.441
- Ligands: NAG-NAG-BMA.6
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain H: N.114
- Ligands: NAG-NAG.7
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain H: N.105
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain H: N.100, T.102
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain H: K.122, E.123, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RUu-FP-1 pAb heavy chain: A
RUu-FP-1 pAb light chain: B
BG505-CH505 Envelope glycoprotein gp120: CDG
BG505-CH505 Transmembrane protein gp41: EFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AD
YG
CE
DF
FH
B
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-3-3-mer
- Ligands
- 3 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 43 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pratap, P.P. et al., Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques. Biorxiv (2024)
- Release Date
- 2025-06-25
- Peptides
- RUu-FP-1 pAb heavy chain: A
RUu-FP-1 pAb light chain: B
BG505-CH505 Envelope glycoprotein gp120: CDG
BG505-CH505 Transmembrane protein gp41: EFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
AD
YG
CE
DF
FH
B